Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use.
Saved in:
| Title: | Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use. |
|---|---|
| Authors: | Kotsiou OS; Laboratory of Human Pathophysiology, School of Health Sciences, Department of Nursing, University of Thessaly, Larissa, Greece. raniakotsiou@gmail.com.; Respiratory Medicine Department, School of Health Sciences, Faculty of Medicine, University of Thessaly, Larissa, Greece. raniakotsiou@gmail.com., Charalampidis D; Thessalia General Clinic, Larissa, Greece., Malizos KN; School of Health Sciences, Faculty of Medicine, University of Thessaly, Larissa, Greece. |
| Source: | Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2026 Jun; Vol. 40 (3), pp. 1177-1186. Date of Electronic Publication: 2025 Nov 13. |
| Publication Type: | Journal Article; Systematic Review; Review |
| Journal Info: | Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-7241 |
|---|---|
| DOI: | 10.1007/s10557-025-07806-x |
